Company Valuation: Europlasma

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 - - - 0.3312 0.3197 0.599
Change - - - - -3.49% 87.37%
Enterprise Value (EV) 1 - - - 11.9 12.24 13.41
Change - - - - 2.85% 9.51%
P/E - - - - - -6.11x
PBR - - - - -0.18x -0.06x
PEG - - - - - -
Capitalization / Revenue - - - 0.02x 0.01x 0.01x
EV / Revenue - - - 0.77x 0.29x 0.19x
EV / EBITDA - - - -1.02x -0.88x -0.62x
EV / EBIT - - - -0.61x -0.47x -0.45x
EV / FCF - - - -2.81x -2.1x -2.31x
FCF Yield - - - -35.6% -47.5% -43.4%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 - - - - - -0.0378
Distribution rate - - - - - -
Net sales 1 6.585 11.24 14.89 15.44 42.82 70.42
EBITDA 1 -6.935 -5.009 -10.96 -11.64 -13.87 -21.66
EBIT 1 -11.6 -11.48 -16 -19.64 -26.29 -29.52
Net income 1 -9.88 -12.67 -15.92 -14.74 -15.29 -35.59
Net Debt 1 3.487 1.704 5.559 11.57 11.92 12.81
Reference price 2 112,100,000.000000 6,070,000.000000 8,743,750.000000 66,250.000000 89.500000 0.231000
Nbr of stocks (in thousands) - - - 0.01 3.57 2,593
Announcement Date 29/04/21 27/04/22 28/04/23 24/05/24 16/06/25 18/06/26
1EUR in Million2EUR
Estimates


P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 605K
30.53x4.49x14.55x1.56% 95.94B
34.33x5.13x16.11x1.03% 75.98B
41.08x5.66x17.06x0.74% 47.95B
28.13x4.94x19.16x0.45% 28.34B
-66.73x4.87x15.75x0.12% 20.12B
26.42x2.58x11.95x-.--% 14.64B
25x - - 0.57% 10.39B
19.33x2.56x12.79x1.55% 9.65B
1963.12x3.64x15.97x-.--% 6.37B
Average 233.47x 4.23x 15.42x 0.67% 30.94B
Weighted average by Cap. 65.60x 4.74x 15.71x 0.97%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Europlasma

Historical PBR trend

Valuation ratios - PBR - Europlasma

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Europlasma

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Europlasma